Hyeon Jeong Kim

Discovery of<i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B

Ahmed Elkamhawy, Sora Paik, Hyeon Jeong Kim et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 29 citations · Full text

Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction

Hyohun Choi, Jang Hoon Lee, Hyuk Kyoon Park et al. · Journal of Korean Medical Science · 2022 · 27 citations · Full text

Positional scanning of natural product hispidol’s ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases

Ahmed H.E. Hassan, Hyeon Jeong Kim, Min Sung Gee et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 24 citations · Full text

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text

Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies

Ahmed Elkamhawy, Sora Paik, Jong‐Hyun Park et al. · Bioorganic Chemistry · 2021 · 16 citations

Medicinal Chemistry, Biochemistry, Potent Safinamide-based Derivatives +12